Applicant, as named in the Orange Book

Organon Llc

Next listed expiry: Xaciato on 22 Sep 2036. 2 products with live protection, 6 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Xaciato NDA 215650 clindamycin phosphate	clindamycin phosphate	22 Sep 2036 patent	patent
Vtama NDA 215272 tapinarof	tapinarof	18 Dec 2039 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (6)

Drug	Ingredient	Earliest generic entry	Basis
Asmanex Hfa NDA 205641 · 3 strengths mometasone furoate	mometasone furoate	open now no listed protection	no listed protection
Asmanex Twisthaler NDA 021067 · 2 strengths mometasone furoate	mometasone furoate	open now no listed protection	no listed protection
Clarinex-D 12 Hour NDA 021313 desloratadine; pseudoephedrine sulfate	desloratadine; pseudoephedrine sulfate	open now no listed protection	no listed protection
Dulera NDA 022518 · 3 strengths formoterol fumarate; mometasone furoate	formoterol fumarate; mometasone furoate	open now no listed protection	no listed protection
Fosamax Plus D NDA 021762 · 2 strengths alendronate sodium; cholecalciferol	alendronate sodium; cholecalciferol	open now no listed protection	no listed protection
Maxalt NDA 020864 rizatriptan benzoate	rizatriptan benzoate	open now no listed protection	no listed protection